Last updated: February 20, 2026
What is the Current Status of NDC 60505-3927?
NDC 60505-3927 refers to a specific drug product listed in the National Drug Code (NDC) database. This code corresponds to a branded or generic pharmaceutical product, but precise identification requires cross-referencing with the FDA’s NDC Directory.
Based on available data, NDC 60505-3927 is associated with Ciprofloxacin Oral Suspension 250 mg/5 mL, produced by a generic manufacturer. It entered the market around 2018 and is marketed primarily for bacterial infections.
How Competitive is the Market for This Product?
Key Market Factors
- Indication: Bacterial infections, including urinary tract infections and respiratory infections.
- Market Size: Global antibiotics market was valued at approximately USD 42 billion in 2020, growing at a CAGR of about 3.5% through 2028 (GlobalData, 2021). The oral ciprofloxacin segment accounts for a significant share of prescription antibiotics.
- Generics Penetration: The drug faces competition from multiple generic formulations. The active ingredient ciprofloxacin is off-patent since 2003, increasing generic market share.
Competitive Landscape
| Brand/Generic |
Manufacturer |
Market Share (Estimated) |
Pricing Range (USD per 100 mL) |
| Cipro (brand) |
Bayer |
10-15% |
$12–$20 |
| Ciprofloxacin generics |
Multiple |
85-90% |
$2.50–$5.50 |
Note: Prices vary significantly by pharmacy, location, and purchase volume.
What Are Price Trends for Ciprofloxacin Oral Suspensions?
Historical Price Trends
- Prices for generic ciprofloxacin oral suspensions have decreased steadily since 2018, paralleling increased market competition.
- From 2018–2020, average retail prices per 100 mL declined approximately 20–30%.
- The COVID-19 pandemic temporarily increased demand for antibiotics, but prices have since normalized.
Current Price Projections
| Year |
Projected Price Range (USD per 100 mL) |
Assumptions |
| 2023 |
$2.50–$4.00 |
Increased generic competition, no major regulatory changes |
| 2024 |
$2.50–$4.00 |
Similar market dynamics, potential supply chain adjustments |
| 2025 |
$2.75–$4.25 |
Slight price increase expected due to inflation and manufacturing costs |
Projected prices remain within the current low range, driven by multiple generic manufacturers. Prices are unlikely to revert to higher brand-name levels unless market incentives or patent protections are re-established.
Regulatory and Policy Impact on Pricing
- Patent Expiry: Ciprofloxacin's patent expired well before 2018, limiting exclusivity.
- Pricing Regulations: No significant price control policies currently target oral antibiotics in the U.S., but shifts toward value-based pricing could influence future costs.
- Importation Policies: Potential for price reduction through importation of lower-cost generics from countries with different regulatory standards.
Market Entry Barriers and Opportunities
Barriers
- High Competition: Numerous generics reduce pricing power.
- Manufacturing Standards: Regulatory compliance costs pose challenges for new entrants.
- Market Saturation: Well-established supply chains and formulary positioning favor existing suppliers.
Opportunities
- Formulation Innovations: Differentiation through improved stability or flavoring.
- Target Markets: Expansion into emerging markets with less mature antibiotic markets.
- Partnerships: Collaborations with healthcare providers to integrate into treatment protocols.
Summary of Key Data and Trends
- NDC 60505-3927 corresponds to ciprofloxacin oral suspension, a generic drug.
- Market share dominated by generics, which collectively account for over 85% of the antibiotic segment.
- Prices have stabilized around $2.50 to $5.50 per 100 mL; future prices likely to remain in this band.
- Market entries are constrained by high competition but offer opportunities through product differentiation and geographic expansion.
Key Takeaways
- The product faces intense generic competition, limiting upward price movement.
- Market prices are stable, with slight downward pressures due to generics.
- Pricing projections indicate little change through 2025 unless regulatory or market shifts occur.
- Opportunities exist in emerging markets, but barriers include supply chain and regulatory hurdles.
FAQs
Q1: How does patent expiration impact the market for ciprofloxacin suspensions?
Patent expiration opens the market to generics, significantly reducing prices and market exclusivity for brand-name products.
Q2: What are key factors influencing ciprofloxacin suspension prices?
Market competition, manufacturing costs, regulatory compliance, and supply chain dynamics.
Q3: Are there notable regional differences in pricing?
Yes. Prices tend to be lower in countries with different regulatory regimes and import policies, especially in regions with fewer patent protections.
Q4: How might future regulatory changes affect the market?
Stricter antibiotic stewardship or price controls could suppress prices, while policies promoting generic manufacturing might further decrease costs.
Q5: What are potential areas for growth for new entrants?
Emerging markets, formulation improvements, and strategic partnerships with healthcare providers.
References
- GlobalData. (2021). Global Antibiotics Market Report 2021.
- FDA NDC Directory. (2023). National Drug Code Directory.
- Healthcare Cost & Utilization Project. (2022). Pharmaceutical Pricing Trends.
